Old Web
English
Sign In
Acemap
>
authorDetail
>
Norman Padre
Norman Padre
Mayo Clinic
Rituximab
Ibritumomab tiuxetan
CD20
Radioimmunotherapy
Medicine
2
Papers
1052
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
R a ndomized C ontrolled T rial o f Y ttrium-90 - Labeled Ibritumomab T iuxetan R adioimmunothera py V ersus Rituximab I mmunotherapy f or P atients W ith R elapsed o r Refractory L ow-Grade, F ollicular, o r T ransformed B -Cell Non-Hodgkin's L ymphoma
2011
Thomas Elmer Witzig
Leo I. Gordon
Fernando Cabanillas
Myron S. Czuczman
Christos Emmanouilides
Robin Joyce
Brad Pohlman
Nancy L. Bartlett
Gregory A. Wiseman
Norman Padre
Pratik S. Multani
Christine A. White
Show All
Source
Cite
Save
Citations (0)
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
2002
Journal of Clinical Oncology
Thomas Elmer Witzig
Leo I. Gordon
Fernando Cabanillas
Myron S. Czuczman
C Emmanouilides
Robin Joyce
Brad Pohlman
Nancy L. Bartlett
Gregory A. Wiseman
Norman Padre
Antonio J. Grillo-Lopez
Pratik S. Multani
Christine A. White
Show All
Source
Cite
Save
Citations (1052)
1